The market has systematically underpriced woman-centric health. I deploy capital where that gap is widest — $2B+ AUM in institutional finance, now 10+ early-stage co-investments across immuno-oncology, precision oncology, and genomic solutions particular to Black women. I make that case in the language capital markets understand.

This focus was shaped by proximity: early detection of ovarian cancer, parental cancer, an MPH investigating maternal mortality and genetic predispositions. That lived expertise sharpens every investment thesis I write and every tool I build.

I built Lacuna — an M&A intelligence platform that maps acquirer-target networks, scores deal probability, and surfaces pricing anomalies across healthcare dealflow.

Quantitative Finance   ·   Applied AI   ·   M&A Intelligence   ·   Oncology & Genomics   ·   Women's Sport

_{Women's sport: a profoundly undervalued lens for health outcomes — and a compelling investment thesis in its own right.}